A citation-based method for searching scientific literature

Katja Seipel, Naomi Porret, Gertrud Wiedemann, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst. Curr Issues Mol Biol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies.
Brian H Santich, Jeong A Park, Hoa Tran, Hong-Fen Guo, Morgan Huse, Nai-Kong V Cheung. Sci Transl Med 2020
26
100

CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah. Hematology Am Soc Hematol Educ Program 2019
10
100

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions.
David C Bishop, Lisa Caproni, Kavitha Gowrishankar, Michal Legiewicz, Kinga Karbowniczek, John Tite, David J Gottlieb, Kenneth P Micklethwaite. Mol Ther Methods Clin Dev 2020
15
100

Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement.
Ying Zhang, Changfeng Zhang, Jin Zhou, Jingren Zhang, Xiaochen Chen, Jia Chen, Pu Wang, Xiuli Sun, Xiaoyan Lou, Wei Qi,[...]. Front Immunol 2021
7
100

CAR-T design: Elements and their synergistic function.
Jayapriya Jayaraman, Michael P Mellody, Andrew J Hou, Ruchi P Desai, Audrey W Fung, An Huynh Thuy Pham, Yvonne Y Chen, Weian Zhao. EBioMedicine 2020
50
100

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.
Liang Lin, Shih-Feng Cho, Lijie Xing, Kenneth Wen, Yuyin Li, Tengteng Yu, Phillip A Hsieh, Hailin Chen, Metin Kurtoglu, Yi Zhang,[...]. Leukemia 2021
23
100

Genetically enhanced T lymphocytes and the intensive care unit.
Tiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, Anca Onaciu, Sergiu Chira, Ciprian Osan, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu,[...]. Oncotarget 2018
4
100

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens.
Soudeh Ghafouri-Fard, Mahnaz Seifi-Alan, Roshanak Shamsi, Ali Esfandiary. Iran J Cancer Prev 2015
10
100

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.
Leila Amini, Sara K Silbert, Shannon L Maude, Loretta J Nastoupil, Carlos A Ramos, Renier J Brentjens, Craig S Sauter, Nirali N Shah, Mohamed Abou-El-Enein. Nat Rev Clin Oncol 2022
4
100



FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma.
Kristi Elkins, Bing Zheng, Maryann Go, Dionysos Slaga, Changchun Du, Suzie J Scales, Shang-Fan Yu, Jacqueline McBride, Ruth de Tute, Andy Rawstron,[...]. Mol Cancer Ther 2012
46
100

The Cancer-Immunity Cycle in Multiple Myeloma.
Mika Casey, Kyohei Nakamura. Immunotargets Ther 2021
1
100

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.
Cesar Sommer, Bijan Boldajipour, Tracy C Kuo, Trevor Bentley, Janette Sutton, Amy Chen, Tao Geng, Holly Dong, Roman Galetto, Julien Valton,[...]. Mol Ther 2019
59
100

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time.
Paula Rodríguez-Otero, Felipe Prósper, Ana Alfonso, Bruno Paiva, Jesús F San Miguel. J Clin Med 2020
11
100

Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
B Van Camp, B G Durie, C Spier, M De Waele, I Van Riet, E Vela, Y Frutiger, L Richter, T M Grogan. Blood 1990
266
100

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
Catalin Constantinescu, Sergiu Pasca, Tiberiu Tat, Patric Teodorescu, Catalin Vlad, Sabina Iluta, Delia Dima, Dana Tomescu, Ecaterina Scarlatescu, Alina Tanase,[...]. J Immunother Cancer 2020
9
100

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma.
Lorraine N Davis, Daniel W Sherbenou. Cancers (Basel) 2021
13
100

Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer.
Anna Stornaiuolo, Barbara Valentinis, Camilla Sirini, Cinzia Scavullo, Claudia Asperti, Dan Zhou, Yeny Martinez De La Torre, Stefano Corna, Monica Casucci, Simona Porcellini,[...]. Hum Gene Ther 2021
2
100

CAR-NK cells: A promising cellular immunotherapy for cancer.
Guozhu Xie, Han Dong, Yong Liang, James Dongjoo Ham, Romee Rizwan, Jianzhu Chen. EBioMedicine 2020
176
100

CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
Fionnuala P O'Connell, Jack L Pinkus, Geraldine S Pinkus. Am J Clin Pathol 2004
168
100

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions.
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, Michael Hudecek, Hermann Einsele, Sophia Danhof. Front Oncol 2020
34
100

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release.
Christina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, Matthew J Bernett, Umesh S Muchhal, Gregory L Moore, Jennitte Stevens, Ryan Case, Joshua T Pearson, Siyuan Liu,[...]. Clin Cancer Res 2019
58
100

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo.
N N Parayath, S B Stephan, A L Koehne, P S Nelson, M T Stephan. Nat Commun 2020
54
100

Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review.
Lærke J B Brandt, Mike B Barnkob, Yale S Michaels, Julia Heiselberg, Torben Barington. Front Immunol 2020
31
100

Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view.
Frederick W Thielen, Annemieke van Dongen-Leunis, Alexander M M Arons, Judith R Ladestein, Peter M Hoogerbrugge, Carin A Uyl-de Groot. Eur J Haematol 2020
14
100

CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Peter Liebisch, Susanne Eppinger, Christine Schöpflin, Gerd Stehle, Gerd Munzert, Hartmut Döhner, Mathias Schmid. Haematologica 2005
45
100

CAR models: next-generation CAR modifications for enhanced T-cell function.
Daniel Abate-Daga, Marco L Davila. Mol Ther Oncolytics 2016
87
100

Targeting B-cell maturation antigen in multiple myeloma.
Yu-Tzu Tai, Kenneth C Anderson. Immunotherapy 2015
108
100

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany.
Nawid Albinger, Jessica Hartmann, Evelyn Ullrich. Gene Ther 2021
58
100

B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
Robert O Carpenter, Moses O Evbuomwan, Stefania Pittaluga, Jeremy J Rose, Mark Raffeld, Shicheng Yang, Ronald E Gress, Frances T Hakim, James N Kochenderfer. Clin Cancer Res 2013
376
100

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.
Lina Zhang, Xuxing Shen, Wenjun Yu, Jing Li, Jue Zhang, Run Zhang, Jianyong Li, Lijuan Chen. Ann Med 2021
2
100

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response.
Jessica B Foster, Namrata Choudhari, Jessica Perazzelli, Julie Storm, Ted J Hofmann, Payal Jain, Phillip B Storm, Norbert Pardi, Drew Weissman, Angela J Waanders,[...]. Hum Gene Ther 2019
34
100

Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options.
Karthik Ramasamy, Francesca Gay, Katja Weisel, Sonja Zweegman, Maria Victoria Mateos, Paul Richardson. Blood Rev 2021
10
100

Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment.
Jort J van der Schans, Niels W C J van de Donk, Tuna Mutis. Front Oncol 2020
17
100

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.
Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei,[...]. J Hematol Oncol 2018
249
100

PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.
Hideto Tamura, Mariko Ishibashi, Mika Sunakawa-Kii, Koiti Inokuchi. Cancers (Basel) 2020
24
100

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.
Michael Maschan, Paolo F Caimi, Jane Reese-Koc, Gabriela Pacheco Sanchez, Ashish A Sharma, Olga Molostova, Larisa Shelikhova, Dmitriy Pershin, Alexey Stepanov, Yakov Muzalevskii,[...]. Nat Commun 2021
3
100

Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma.
Johanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, Birgit Kainz, Thomas W Grunt, Markus Raderer, Bernadette Hilgarth, Johannes Drach, Heinz Ludwig, Heinz Gisslinger,[...]. Eur J Clin Invest 2012
50
100

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
J Joseph Melenhorst, Gregory M Chen, Meng Wang, David L Porter, Changya Chen, McKensie A Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao,[...]. Nature 2022
48
100

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.
Margaux Lejeune, Murat Cem Köse, Elodie Duray, Hermann Einsele, Yves Beguin, Jo Caers. Front Immunol 2020
30
100

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma.
Aina Oliver-Caldes, Raquel Jiménez, Marta Español-Rego, Maria Teresa Cibeira, Valentín Ortiz-Maldonado, Luis F Quintana, Paola Castillo, Francesca Guijarro, Natalia Tovar, Mercedes Montoro,[...]. J Immunother Cancer 2021
2
100

The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration.
Marco E Bianchi, Rosanna Mezzapelle. Front Immunol 2020
45
100


NKG2D: A Master Regulator of Immune Cell Responsiveness.
Felix M Wensveen, Vedrana Jelenčić, Bojan Polić. Front Immunol 2018
79
100

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.
Mohamed-Reda Benmebarek, Clara Helke Karches, Bruno Loureiro Cadilha, Stefanie Lesch, Stefan Endres, Sebastian Kobold. Int J Mol Sci 2019
132
100

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
M A Dimopoulos, P Moreau, E Terpos, M V Mateos, S Zweegman, G Cook, M Delforge, R Hájek, F Schjesvold, M Cavo,[...]. Ann Oncol 2021
94
100


The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma.
Deming Duan, Keke Wang, Cheng Wei, Dudu Feng, Yonghua Liu, Qingyan He, Xing Xu, Chunling Wang, Shuping Zhao, Leili Lv,[...]. Front Immunol 2021
11
100

Recent advances in CAR-T cell engineering.
Ruihao Huang, Xiaoping Li, Yundi He, Wen Zhu, Lei Gao, Yao Liu, Li Gao, Qin Wen, Jiang F Zhong, Cheng Zhang,[...]. J Hematol Oncol 2020
82
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.